Retinopathy of Prematurity Update on Classification, Screening, and Therapy

被引:2
作者
Li, Jeany Q. [1 ]
Kellner, Ulrich [2 ]
Lorenz, Birgit [3 ]
Stahl, Andreas [4 ]
Krohne, Tim U. [5 ]
机构
[1] Uniklin Koln, Zentrum Augenheilkunde, Kerpener St 62, D-50937 Cologne, Germany
[2] FU Berlin, Klinikum Benjamin Franklin, Berlin, Germany
[3] Univ Regensburg, Kinderophthalmol Strabol Neuroophthalmol & Ophiha, Regensburg, Germany
[4] Univ Augenklin Freiburg, Klin & Poliklin Augenheilkunde, Greifswald, Germany
[5] Uniklin Koln, Zentrum Augenheilkunde, Netzhauterkrankungen & Vitreoretinale Chirurg, Cologne, Germany
关键词
retinopathy of prematurity; screening; classification; treatment; guideline; INTERNATIONAL CLASSIFICATION; INTRAVITREAL BEVACIZUMAB; RANIBIZUMAB; REACTIVATION; MANAGEMENT; EFFICACY; ROP;
D O I
10.1055/a-1758-3020
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Retinopathy of prematurity (ROP) is a leading cause of preventable childhood blindness. This proliferative retinal vascular disease affects only prematurely born infants. Major risk factors include low gestational age and prolonged postnatal oxygen supplementation. ROP screening allows for timely identification of treatment-requiring infants and thus significantly reduces the risk of severe visual impairment and blindness from ROP. Current treatment options comprise retinal laser coagulation and intravitreal anti-vascular endothelial growth factor (VEGF) therapy. We provide a review of scientific data and current treatment recommendations, with special attention to the updated German guideline on ROP screening, the statement of the German ophthalmological societies on anti-VEGF therapy of ROP, and the new third edition of the International Classification of Retinopathy of Prematurity (ICROP3).
引用
收藏
页码:346 / 363
页数:18
相关论文
共 40 条
[1]   Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab [J].
Andrassi-Darida, Monika ;
Mais, Christine ;
Stieger, Knut ;
Lorenz, Birgit .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2020, 237 (12) :1468-1476
[2]  
[Anonymous], 2020, OPHTHALMOLOGE, V117, P873, DOI [10.1007/s00347-020-01170-x, DOI 10.1007/S00347-020-01170-X]
[3]   Age terminology during the perinatal period [J].
Blackmon, LR ;
Batton, DG ;
Bell, EF ;
Denson, SE ;
Engle, WA ;
Kanto, WP ;
Martin, GI ;
Stark, A ;
Barrington, KJ ;
Raju, TNK ;
Riley, LE ;
Tomashek, KM ;
Wallman, C .
PEDIATRICS, 2004, 114 (05) :1362-1364
[4]   International Classification of Retinopathy of Prematurity, Third Edition [J].
Chiang, Michael F. ;
Quinn, Graham E. ;
Fielder, Alistair R. ;
Ostmo, Susan R. ;
Chan, R. V. Paul ;
Berrocal, Audina ;
Binenbaum, Gil ;
Blair, Michael ;
Campbell, J. Peter ;
Capone, Antonio ;
Chen, Yi ;
Dai, Shuan ;
Ells, Anna ;
Fleck, Brian W. ;
Good, William V. ;
Hartnett, M. Elizabeth ;
Holmstrom, Gerd ;
Kusaka, Shunji ;
Kychenthal, Andres ;
Lepore, Domenico ;
Lorenz, Birgit ;
Martinez-Castellanos, Maria Ana ;
Ozdek, Sengul ;
Ademola-Popoola, Dupe ;
Reynolds, James D. ;
Shah, Parag K. ;
Shapiro, Michael ;
Stahl, Andreas ;
Toth, Cynthia ;
Vinekar, Anand ;
Visser, Linda ;
Wallace, David K. ;
Wu, Wei-Chi ;
Zhao, Peiquan ;
Zin, Andrea .
OPHTHALMOLOGY, 2021, 128 (10) :E51-E68
[5]   Children with blindness - major causes, developmental outcomes and implications for habilitation and educational support: a two-decade, Swedish population-based study [J].
de Verdier, Kim ;
Ulla, Ek ;
Lofgren, Stefan ;
Fernell, Elisabeth .
ACTA OPHTHALMOLOGICA, 2018, 96 (03) :295-300
[6]   Screening Examination of Premature Infants for Retinopathy of Prematurity [J].
Fierson, Walter M. .
PEDIATRICS, 2018, 142 (06)
[7]  
GARNER A, 1984, PEDIATRICS, V74, P127
[8]   Refractive Outcomes Following Bevacizumab Monotherapy Compared With Conventional Laser Treatment A Randomized Clinical Trial [J].
Geloneck, Megan M. ;
Chuang, Alice Z. ;
Clark, W. Lloyd ;
Hunt, Michael G. ;
Norman, Alan A. ;
Packwood, Eric A. ;
Tawansy, Khaled A. ;
Mintz-Hittner, Helen A. .
JAMA OPHTHALMOLOGY, 2014, 132 (11) :1327-1333
[9]   Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006-2015: a population-based analysis [J].
Gerull, Roland ;
Brauer, Viviane ;
Bassler, Dirk ;
Laubscher, Bernard ;
Pfister, Riccardo E. ;
Nelle, Mathias ;
Muller, Beatrice ;
Gerth-Kahlert, Christina ;
Adams, Mark .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2018, 103 (04) :F337-F342
[10]   The international classification of retinopathy of prematurity revisited [J].
Gole, GA ;
Ells, AL ;
Katz, X ;
Holmstrom, G ;
Fielder, AR ;
Capone, A ;
Flynn, JT ;
Good, WG ;
Holmes, JM ;
McNamara, JA ;
Palmer, EA ;
Quinn, GE ;
Shapiro, MJ ;
Trese, MGJ ;
Wallace, DK .
ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (07) :991-999